162 related articles for article (PubMed ID: 19534265)
1. Rapid prescreening as a quality assurance measure in cervical cytology.
Repse-Fokter A; Caks-Golec T
Acta Cytol; 2009; 53(3):268-70. PubMed ID: 19534265
[TBL] [Abstract][Full Text] [Related]
2. Rapid prescreening of Papanicolaou smears: a practical and efficient quality control strategy.
Djemli A; Khetani K; Auger M
Cancer; 2006 Feb; 108(1):21-6. PubMed ID: 16302251
[TBL] [Abstract][Full Text] [Related]
3. Correlation of cytotechnologists' parameters with their performance in rapid prescreening of papanicolaou smears.
Djemli A; Khetani K; Case BW; Auger M
Cancer; 2006 Oct; 108(5):306-10. PubMed ID: 16948125
[TBL] [Abstract][Full Text] [Related]
4. Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening?
Kanber Y; Charbonneau M; Auger M
Cancer Cytopathol; 2015 Dec; 123(12):739-44. PubMed ID: 26348845
[TBL] [Abstract][Full Text] [Related]
5. Rapid cervicovaginal smear screening: method of quality control and assessing individual cytotechnologist performance.
Pajtler M; Audy-Jurković S; Skopljanac-Macina L; Antulov J; Barisić A; Milicić-Juhas V
Cytopathology; 2006 Jun; 17(3):121-6. PubMed ID: 16719854
[TBL] [Abstract][Full Text] [Related]
6. Rapid prescreen of cervical liquid-based cytology preparations: results of a study in an academic medical center.
Frable WJ; Pedigo MA; Powers CN; Yarrell C; Ortiz B; Clark ME; Ebron T
Diagn Cytopathol; 2012 Aug; 40(8):691-7. PubMed ID: 22807384
[TBL] [Abstract][Full Text] [Related]
7. Metaanalysis of the accuracy of rapid prescreening relative to full screening of pap smears.
Arbyn M; Schenck U; Ellison E; Hanselaar A
Cancer; 2003 Feb; 99(1):9-16. PubMed ID: 12589640
[TBL] [Abstract][Full Text] [Related]
8. Rapid pre-screening of cervical smears as a method of internal quality control in a cervical screening programme.
Tavares SB; de Sousa NL; Manrique EJ; de Albuquerque ZB; Zeferino LC; Amaral RG
Cytopathology; 2008 Aug; 19(4):254-9. PubMed ID: 18476988
[TBL] [Abstract][Full Text] [Related]
9. Patients with epithelial cell abnormality in PAP smears: correlation of results with follow-up smears and cervical biopsies.
Türkmen IÇ; Başsüllü N; Korkmaz P; Günenç B; Baykal CM; Güdücü N; Işçı H; Dünder I; Doğusoy GB
Turk Patoloji Derg; 2013; 29(3):179-84. PubMed ID: 24022307
[TBL] [Abstract][Full Text] [Related]
10. Comparison of false negative rates between 100% rapid review and 10% random full rescreening as internal quality control methods in cervical cytology screening.
Lee BC; Lam SY; Walker T
Acta Cytol; 2009; 53(3):271-6. PubMed ID: 19534266
[TBL] [Abstract][Full Text] [Related]
11. 100% rapid rescreening for quality assurance in a quality control program in a public health cytologic laboratory.
Mattosinho de Castro Ferraz Mda G; Dall' Agnol M; di Loreto C; Pirani WM; Utagawa ML; Pereira SM; Sakai YI; Feres CL; Shih LW; Yamamoto LS; Rodrigues RO; Shirata NK; Longatta Filho A
Acta Cytol; 2005; 49(6):639-43. PubMed ID: 16450904
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the SurePath liquid-based Papanicolaou smear with the conventional Papanicolaou smear in a multisite direct-to-vial study.
Fremont-Smith M; Marino J; Griffin B; Spencer L; Bolick D
Cancer; 2004 Oct; 102(5):269-79. PubMed ID: 15386329
[TBL] [Abstract][Full Text] [Related]
13. Positive predictive value of liquid-based and conventional cervical Papanicolaou smears reported as malignant.
Uyar DS; Eltabbakh GH; Mount SL
Gynecol Oncol; 2003 May; 89(2):227-32. PubMed ID: 12713984
[TBL] [Abstract][Full Text] [Related]
14. Managing atypical squamous cells of undetermined significance in Papanicolaou smears.
Morin C; Bairati I; Bouchard C; Fortier M; Roy M; Moore L; Meisels A
J Reprod Med; 2001 Sep; 46(9):799-805. PubMed ID: 11584480
[TBL] [Abstract][Full Text] [Related]
15. Costs and outcomes of PAPNET secondary screening technology for cervical cytologic evaluation. A community hospital's experience.
Brotzman GL; Kretzchmar S; Ferguson D; Gottlieb M; Stowe C
Arch Fam Med; 1999; 8(1):52-5. PubMed ID: 9932072
[TBL] [Abstract][Full Text] [Related]
16. Atypical squamous cells of undetermined significance in liquid-based cytologic specimens: results of reflex human papillomavirus testing and histologic follow-up in routine practice with comparison of interpretive and probabilistic reporting methods.
Levi AW; Kelly DP; Rosenthal DL; Ronnett BM
Cancer; 2003 Aug; 99(4):191-7. PubMed ID: 12925979
[TBL] [Abstract][Full Text] [Related]
17. Comparison of human papillomavirus DNA testing and repeat Papanicolaou test in women with low-grade cervical cytologic abnormalities: a randomized trial. HPV Effectiveness in Lowgrade Paps (HELP) Study No. 1 Group.
Lytwyn A; Sellors JW; Mahony JB; Daya D; Chapman W; Ellis N; Roth P; Lorincz AT; Gafni A
CMAJ; 2000 Sep; 163(6):701-7. PubMed ID: 11022584
[TBL] [Abstract][Full Text] [Related]
18. Quality metrics in cervical cytopathology: A single institutional study.
Senthil Kumar D; Ravikumar G
Cytopathology; 2022 Mar; 33(2):230-235. PubMed ID: 34854153
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of rapid prescreening and 10% rescreening in liquid-based Papanicolaou testing.
Currens HS; Nejkauf K; Wagner L; Raab SS
Am J Clin Pathol; 2012 Jan; 137(1):150-5. PubMed ID: 22180489
[TBL] [Abstract][Full Text] [Related]
20. Improved quality-control detection of false-negative Pap smears using the Autopap 300 QC system.
Marshall CJ; Rowe L; Bentz JS
Diagn Cytopathol; 1999 Mar; 20(3):170-4. PubMed ID: 10086244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
